	Transforming growth factor-Î² and integrins: key players in EMT and breast cancer progression. Cancer Cell Int Ramalingam PS, Afzal M, Rekha MM, Sahoo S, Pandey SN, Maji C, Goyal K, Ali H, Singh SK, Gupta G, Hussain MS, Mekala JR, Arumugam S. PMID: 41673648 [PubMed - as supplied by publisher]
	An analysis of the factors influencing bone health literacy among middle-aged and elderly breast cancer patients undergoing endocrine therapy: a mixed-methods study based on COM-B theory. BMC Womens Health Gai Z, Wang N, Gai Z, Liu L, Zhang S, Li X, Ma X, Yan B, Cao B. PMID: 41673643 [PubMed - as supplied by publisher]
	Co-adapting the evaluation strategy for a patient-centered interprofessional training program in cancer care: a modified mixed-methods Delphi study. BMC Med Educ Hama H, Fragner T, Kirchheiner K, Grabovac I. PMID: 41673642 [PubMed - as supplied by publisher]
	Predicting microvascular invasion in hepatocellular carcinoma using US features combined with clinicopathological characteristics: a multicenter study. World J Surg Oncol Yang L, Li T, Wang L, Liu L, Wang J, Hao Y. PMID: 41673635 [PubMed - as supplied by publisher]
	Factors related to implementation of outpatient palliative care for advanced cancer patients in a safety-net health system: a qualitative study using the theoretical domains framework. BMC Palliat Care DiMartino L, Repasky EC, Skinner CS, Sadeghi N, Hong AS, Rhodes R, Hogan TP. PMID: 41673632 [PubMed - as supplied by publisher]
	Association of soluble tumor necrosis factor receptor 1 with tau pathology, brain atrophy, and cognitive decline: a longitudinal study. BMC Med Zhang Y, Sun L, Zhao Y, Zhang Z, Chen H, Zhao M, Miao Z, Wang W, Xu X, Alzheimer. PMID: 41673623 [PubMed - as supplied by publisher]
	Surufatinib plus tislelizumab as later-line therapy for metastatic colorectal cancer: a single-arm, phase II trial. BMC Cancer Xu H, Yan Y, Niu J, Cao L, Chen W, Li M, Luo H, Ke L, Wu S, Wang G, He Y. PMID: 41673617 [PubMed - as supplied by publisher]
	Mechanism of action of MiR-330-5p targeting ITGA5 in the regulation of proliferation, migration, and invasionof gastric cancer. BMC Cancer Wang JF, Wei JM, He T, Hu JW, Zhang JN, Liu LZ. PMID: 41673591 [PubMed - as supplied by publisher]
	Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment. Sci Rep Morikawa K, Takata S, Tanaka H, Itani H, Ishihara M, Horiuchi K, Kato Y, Ikemura S, Nakagawa H, Nakahara Y, Seki Y, Bessho A, Takahashi N, Hayashi K, Endoh T, Takeyama K, Maekura T, Takigawa N, Kawase A, Endoh M, Nemoto K, Kishi K, Soejima K, Okuma Y, Yoshimura K, Saigusa D, Kanai Y, Ueda K, Togashi A, Matsutani N, Seki N. PMID: 41673455 [PubMed - as supplied by publisher]
	A lncRNA and radiomics-based model for predicting the response of non-small cell lung cancer to chemo- and radio-therapy. Sci Rep Ye F, Yin Y, Wang J, Wang J, Yang J, Zhang J, Zhang Y, Qi J, Zhu Q, Zhang Y, Ji H, Hu Z, Hong B, Wang H. PMID: 41673451 [PubMed - as supplied by publisher]
	Cardiovascular and prostate cancer risk associated to testosterone replacement therapy - a systematic review and meta-analysis of 41 randomized controlled trials. Int J Impot Res García-Becerra CA, Arias-Gallardo MI, Juárez-García JE, Soltero-Molinar V, Parra-Camaño LF, Rivera-Rocha MI, García-Becerra N, García-Gutiérrez CM. PMID: 41673435 [PubMed - as supplied by publisher]
	Neighborhood obesogenic factors and breast cancer risk and mortality in the Southern community cohort study. Sci Rep Kumsa FA, Fowke JH, Hashtarkhani S, White BM, Shrubsole MJ, Shaban-Nejad A. PMID: 41673434 [PubMed - as supplied by publisher]
	Enhanced breast cancer detection framework based on YOLOv11n with multi-scale feature calibration. Sci Rep He Z, Zhang C, Liang C, Li W. PMID: 41673415 [PubMed - as supplied by publisher]
	HMI-LUSC: A Histological Hyperspectral Imaging Dataset for Lung Squamous Cell Carcinoma. Sci Data Yan Z, Huang H, Guo Y, Shi J, Geng R, Zhang J, Chen Y, Nie Y. PMID: 41673396 [PubMed - as supplied by publisher]
	HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications. Clin Exp Med Shen X, Huang H, Sheng J, Tang X. PMID: 41673369 [PubMed - as supplied by publisher]
	Standing the test of time: diagnostic accuracy of the Edmonton Symptom Assessment System-Revised (ESAS-r) for anxiety and depression screening. Support Care Cancer Lambert SD, Moore A, Belzile E, Rosberger Z, Pelland MÈ, Hijal T, Haggerty J, Ould Brahim L, Germeil F, Alizadeh M, Lemy-Dantica J. PMID: 41673361 [PubMed - indexed for MEDLINE]
	A pilot randomized controlled trial comparing the feasibility and preliminary effects of different forms of exercise-related social support for older adult survivors of cancer. Support Care Cancer Smith-Turchyn J, Sinclair S, O'Loughlin E, Innes A, Richardson J, Pillips S, Beauchamp M, Thabane L, Wrosch C, Sabiston CM. PMID: 41673350 [PubMed - indexed for MEDLINE]
	Work challenges and cancer-related cognitive impairment: level of education accounts for unmet needs beyond cognitive impairment severity. Support Care Cancer Haywood D, Rossell SL, Henneghan A, Baughman FD, Haywood J, Dauer E, Hegde A, Moustafa AA, Hart NH. PMID: 41673337 [PubMed - indexed for MEDLINE]
	What are the effects of pilates and dance on upper limb functionality in women post-breast cancer surgery? a randomized three-arm clinical trial. Support Care Cancer Boing L, de Bem Fretta T, Dias M, Marinho A, Lynch B, Bergmann A, da Silveira J, Groth LA, de Azevedo Guimarães AC. PMID: 41673315 [PubMed - indexed for MEDLINE]
	PD1 blockers work best when used in the morning, suggests cancer chronotherapy trial. Nat Rev Drug Discov Mullard A. PMID: 41673277 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1908789

Page 1 of 95440



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy